Baicalin Inhibits EMT through PDK1/AKT Signaling in Human Nonsmall Cell Lung Cancer

Figure 4

Baicalin inhibited the PDK1/AKT signaling pathway in NSCLC. (a–c) Immunofluorescence staining for p-PDK1 and p-AKT after treating with baicalin. (d) Protein expression levels of p-PDK1 and p-AKT after treating with baicalin. (e, f) The p-PDK1 and p-AKT expression levels in tumor tissues of subcutaneously transplanted tumor mice.

(a)

(b)

(c)

(d)

(e)

(f)